The article you requested is
Fluoxetine Efficacy in Social Phobia
J Clin Psychiatry 1997;58:124-125 [letter]
Copyright 1997 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
- Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: The serotonin selective reuptake inhibitors (SSRIs) are
establishing themselves as useful medications for the treatment
of social phobia. While none are FDA approved for this indication,
open reports and controlled trials suggest efficacy for all
members of this class. More than 2 years ago, Ringold described
two patients with social phobia who were successfully
treated with paroxetine after failing to respond to fluoxetine
and sertraline. Likewise, a patient I have been treating also
showed a preferential response to one of the SSRIs, but in this
case it was fluoxetine.